Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Gemcitabine plus Ifosfamind as
second line chemotherapy in advanced transitional cell carcinoma in terms of response rate
and overall survival .